Imelda Lambkin

USPTO Granted Patents = 10 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 101(Granted Patents)

Location History:

Dublin, IE (2004 - 2009)
Sutton, IE (2005 - 2011)

Company Filing History:

3 out of 22

Merrion Research III Limited

Elan Corporation, Plc

patents

4. 2 out of 3

Merrion Research I Limited

6. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2011

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8017727 - Conjugates of membrane translocating agents and pharmaceutically active agents (2011-09-13),

2. 7638599 - Conjugates of membrane translocating agents and pharmaceutically active agents (2009-12-29),

3. 7485321 - Peyer's patch and/or M-cell targeting ligands (2009-02-03),

4. 7268214 - Membrane translocating peptide drug delivery system (2007-09-11),

5. 7166296 - Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 (2007-01-23),

6. 7135457 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-11-14),

7. 7053177 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-05-30),

8. 6916789 - Peyer's patch and/or M-cell targeting ligands (2005-07-12),

9. 6780846 - Membrane translocating peptide drug delivery system (2004-08-24),

10. 6703362 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2004-03-09),

Title: The Innovative Journey of Inventor Imelda Lambkin

Introduction

Imelda Lambkin, hailing from Sutton, Ireland, is a prominent inventor known for her contributions to the field of biochemistry and pharmaceutical sciences. With a remarkable portfolio of 10 patents, her work focuses on the development of advanced membrane translocating agents that play a crucial role in drug delivery systems.

Latest Patents

Imelda's latest patents include groundbreaking innovations in the area of membrane translocation peptides. These patents encompass conjugates of membrane translocating agents and pharmaceutically active agents, detailing compositions comprising these peptides, as well as chimeric molecules. Her inventions outline methods that can effectively achieve transmembrane transport of various agents, showcasing her commitment to enhancing drug delivery mechanisms.

Career Highlights

Over the course of her career, Imelda has made significant strides in her field while working with reputable companies such as Merrion Research III Limited and Elan Corporation Plc. Her developments have not only advanced scientific understanding but also aided in creating innovative biomedical solutions.

Collaborations

Imelda has collaborated with esteemed colleagues, including Daniel Joseph O'Mahony and Vernon L Alvarez. These partnerships have allowed for a robust exchange of ideas and expertise, further enhancing the impact of her inventions on the pharmaceutical industry.

Conclusion

In summary, Imelda Lambkin exemplifies the spirit of innovation and dedication found in the ranks of female inventors. Her extensive work in developing advanced delivery systems for pharmaceutical agents continues to inspire future generations of scientists and inventors, solidifying her legacy in the field of medicine and beyond.

This text is generated by artificial intelligence and may not be accurate.